TY - JOUR
AB - Following the publication of this paper, it was drawn to the Editors’ attention by a concerned reader that certain of the western blotting data shown in Fig. 3C, 4D, 5A and 6D bore unexpected similarities to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [the original article was published in Oncology Reports 34: 3272‑3279, 2015; DOI: 10.3892/or.2015.4321]
AD - Department of Pediatric Gastroenterology, The First Hospital, jilin University, Changchun, jilin 130021, P.R. China
The Experiment Center, College of Basic Medical Sciences, jilin University, Changchun, jilin 130021, P.R. China
Department of Hepatology, The First Hospital, jilin University, Changchun, jilin 130021, P.R. China
AU - Pang,Xiaoli
AU - Huang,Kexin
AU - Zhang,Qianqian
AU - Zhang,Yujiao
AU - Niu,Junqi
DA - 2021/08/01
DO - 10.3892/or.2021.8113
IS - 2
JO - Oncol Rep
KW - hepatocellular carcinoma
miR-154
ZEB2
tumor suppressor
PY - 2021
SN - 1021-335X
1791-2431
SP - 161
ST - [Retracted] miR‑154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor
T2 - Oncology Reports
TI - [Retracted] miR‑154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor
UR - https://doi.org/10.3892/or.2021.8113
VL - 46
ER -